Where to buy Panitumumab

Panitumumab is a drug that treats colorectal cancer that has spread to other parts of the body. It is used alone or in combination with other cancer drugs in people whose tumors have a normal ("wild-type") copy of a gene called RAS. Panitumumacontains the active substancepanitumumab, a monoclonal antibody, a protein designed to attach to and block a target called EGFR on certain cells, including some tumor cells.

Thus these tumor cells are no longer able to receive the messages passed through EGFR that they need to grow and spread to other parts of the body. Panitumumab does not appear to work against tumor cells containing mutated (abnormal) RAS genes. This is because these types of cells do not depend on EGFR for growth and can continue to grow uncontrollably even if EGFR is blocked. Panitumumab is only available by prescription, and treatment should be supervised by a physician experienced in cancer treatment and should be initiated only after the presence of wild-type RAS has been confirmed by an experienced laboratory using a validated test method.

It is understood that the original version of panitumumab has not yet been launched in China, and therefore it has not been covered by medical insurance. The price of the Hong Kong original version of panitumumab sold in Hong Kong, China100mg/5mL may be around RMB 9,000 (the price may fluctuate due to exchange rates). This drug may be sold in local hospitals or pharmacies, and patients in need need to purchase it through formal channels. There are currently no generic drugs of Panitumumab on the market. If a patient has a need to purchase Panitumumab, please consult a medical consultant for specific prices and more drug information.